Literature DB >> 20521494

Annual report of the National Influenza Surveillance Scheme, 2008.

Marlena Kaczmarek1, Rhonda Owen, Ian G Barr.   

Abstract

The 2008 influenza season was moderate overall, with fewer laboratory-confirmed cases and influenza-like illness (ILI) presentations than in 2007, which was the most severe influenza season since national reporting of influenza began in 2001. In 2008, the number of laboratory-confirmed notifications for influenza was 1.9 times higher than the 5-year mean. High notification rates were reflected in an increase in presentations with ILI to sentinel general practices and emergency departments. Notification rates were highest in the 0-4 year age group. Unusually, the season was predominantly due to influenza B, with 54% of notifications being influenza B and 43% being influenza A (3% type unknown). The rate of influenza B was higher among the younger age groups, compared with influenza A, which was more common in the older age groups. Of influenza viruses circulating during the 2008 season, A(H3) viruses were predominant and were antigenically similar to the 2008 A(H3) vaccine strain, while the majority of A(H1) strains showed significant drift away from the 2008 A(H1) vaccine strain. There were approximately equal proportions of viruses from the 2 influenza B lineages B/Yamagata and B/Victoria.

Mesh:

Year:  2010        PMID: 20521494

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  9 in total

1.  Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adults.

Authors:  James M McCaw; Peter F Howard; Peter C Richmond; Michael Nissen; Theo Sloots; Stephen B Lambert; Michael Lai; Michael Greenberg; Terry Nolan; Jodie McVernon
Journal:  BMC Infect Dis       Date:  2012-12-11       Impact factor: 3.090

2.  Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.

Authors:  James E Fielding; Kristina A Grant; Georgina Papadakis; Heath A Kelly
Journal:  BMC Infect Dis       Date:  2011-06-14       Impact factor: 3.090

3.  Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain.

Authors:  Troy T Rohn; Lindsey W Catlin
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

4.  Epidemiological and Clinical Characteristics of Influenza Outbreaks Among Children in Chongqing, China.

Authors:  Xuchen Meng; Han Zhao; Rong Ou; Qing Zeng; Huiqun Lv; Hua Zhu; Mengliang Ye
Journal:  Front Public Health       Date:  2022-04-15

5.  Forecasting influenza outbreak dynamics in Melbourne from Internet search query surveillance data.

Authors:  Robert Moss; Alexander Zarebski; Peter Dawson; James M McCaw
Journal:  Influenza Other Respir Viruses       Date:  2016-03-07       Impact factor: 4.380

6.  Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial.

Authors:  Peter F Howard; James M McCaw; Peter C Richmond; Michael Nissen; Theo Sloots; Stephen B Lambert; Michael Lai; Michael Greenberg; Terry Nolan; Jodie McVernon
Journal:  Influenza Other Respir Viruses       Date:  2012-06-19       Impact factor: 4.380

7.  Incidence of acute respiratory infections in Australia.

Authors:  Y Chen; M D Kirk
Journal:  Epidemiol Infect       Date:  2013-10-08       Impact factor: 4.434

8.  Epidemiology of Australian Influenza-Related Paediatric Intensive Care Unit Admissions, 1997-2013.

Authors:  Marlena C Kaczmarek; Robert S Ware; Mark G Coulthard; Julie McEniery; Stephen B Lambert
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

9.  Low utilisation of diagnostic microbiology for community acquired pneumonia in regional Victoria.

Authors:  Cameron J Jeremiah; Liam M Hannan; Rob Baird; Grant Phelps; Brett Knight
Journal:  Pathology       Date:  2013-02       Impact factor: 5.306

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.